| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(90)90129-3 |
| P698 | PubMed publication ID | 2225069 |
| P2093 | author name string | Cullen BR | |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 655-657 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | The HIV-1 Tat protein: an RNA sequence-specific processivity factor? | |
| P478 | volume | 63 |
| Q36736780 | A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy. |
| Q52509860 | A haploid expressed gene cluster exists as a single chromatin domain in human sperm. |
| Q36740883 | A heat-labile factor promotes premature 3' end formation in exon 1 of the murine adenosine deaminase gene in a cell-free transcription system |
| Q36829057 | A minimal lentivirus Tat |
| Q35874415 | A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade |
| Q37587432 | A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins |
| Q39873975 | A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection |
| Q40113669 | A novel cis-acting element that controls transcription of human immunodeficiency virus type 1 DNA, depending on cell type |
| Q36632636 | A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. |
| Q34197864 | A triad of lys12, lys41, arg78 spatial domain, a novel identified heparin binding site on tat protein, facilitates tat-driven cell adhesion |
| Q36354858 | Activation of HIV transcription by Tat |
| Q33938737 | Activation of HIV-1 pre-mRNA 3' processing in vitro requires both an upstream element and TAR. |
| Q36654634 | Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators. |
| Q35071007 | Alternative 3' processing ofXenopusα-tubulin mRNAs; efficient use of a CAUAAA polyadenylation signal |
| Q41156264 | An apparent pause site in the transcription unit of the rabbit α-globin gene |
| Q35112663 | An overview: Human Polyomavirus JC Virus and its Associated Disorders |
| Q41532091 | Analysis of 3' terminals of human immunodeficiency virus type 1 transcripts in persistently infected cells |
| Q41079020 | Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. |
| Q36828521 | Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation |
| Q27480296 | BHK cell proteins that bind to the 3' stem-loop structure of the West Nile virus genome RNA |
| Q24609153 | Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53 |
| Q48826334 | Brain specific proteins binding to the 3' UTR of the 5-HT2C receptor mRNA. |
| Q24315725 | CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription |
| Q39539781 | Characterization of a major histocompatibility complex class II X-box-binding protein enhancing tat-induced transcription directed by the human immunodeficiency virus type 1 long terminal repeat |
| Q41576182 | Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. |
| Q36689048 | Characterization of the transcriptional trans activator of human foamy retrovirus |
| Q34057748 | Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. |
| Q37251783 | Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator |
| Q68188961 | Conformation of the TAR RNA-Arginine Complex by NMR Spectroscopy |
| Q71514644 | Conformational heterogeneity in two regions of TAT results in structural variations of this protein as a function of HIV-1 isolates |
| Q36697484 | Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure |
| Q42176445 | Control of transcription arrest in intron 1 of the murine adenosine deaminase gene |
| Q40504544 | Cooperation between upstream and downstream elements of the adenovirus major late promoter for maximal late phase-specific transcription |
| Q36798014 | Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein |
| Q36828450 | DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1 |
| Q37137126 | Designed DNA probes from the neocarzinostatin family: impact of glycosyl linkage stereochemistry on bulge base binding |
| Q35792991 | Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains |
| Q35083490 | Differential distribution of the JC virus receptor-type sialic acid in normal human tissues |
| Q40504951 | Distinctcis-acting regions in U3 regulatetrans-activation of the human spumaretrovirus long terminal repeat by the viralbel1 gene product |
| Q41139329 | Effect of RNA secondary structure on polyadenylation site selection |
| Q39721955 | Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat. |
| Q36633736 | Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides. |
| Q36486560 | Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein |
| Q40190812 | Evidence for BAG3 modulation of HIV-1 gene transcription. |
| Q37509715 | Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif |
| Q30424377 | Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand |
| Q42636308 | Function of E. coli RNA polymerase sigma factor sigma 70 in promoter-proximal pausing |
| Q33930854 | Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation |
| Q24655684 | Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat |
| Q36333797 | Genetic analysis and gene expression of human immunodeficiency virus |
| Q34120071 | HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter |
| Q24568360 | HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state |
| Q35937536 | HIV-1 Tat protein promotes formation of more-processive elongation complexes |
| Q35928622 | Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation |
| Q36962142 | High-level expression of the rat whey acidic protein gene is mediated by elements in the promoter and 3' untranslated region |
| Q35384285 | How the phage lambda N gene product suppresses transcription termination: communication of RNA polymerase with regulatory proteins mediated by signals in nascent RNA |
| Q37644114 | Human immunodeficiency virus as a prototypic complex retrovirus. |
| Q36640545 | Human immunodeficiency virus type 1 infection of the brain |
| Q40065232 | Human immunodeficiency virus vectors for inducible expression of foreign genes |
| Q40067137 | Identification and characterization of the bovine immunodeficiency-like virus tat gene |
| Q42614068 | Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland |
| Q33845527 | Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design |
| Q36701401 | In vitro binding of human T-cell leukemia virus rex proteins to the rex-response element of viral transcripts |
| Q38334658 | Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element |
| Q33930741 | Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators |
| Q59360038 | Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas |
| Q33933045 | Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription |
| Q37603547 | Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter |
| Q39878385 | JC virus-induced Progressive Multifocal Leukoencephalopathy |
| Q58322056 | Leucoencefalopatía multifocal progresiva: desde el origen a 2008 |
| Q35403061 | Mechanism of action of regulatory proteins encoded by complex retroviruses |
| Q34638628 | Molecular biology and immunoregulation of human neurotropic JC virus in CNS. |
| Q38320613 | Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus. |
| Q56920288 | New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview |
| Q24568366 | Novel mechanism and factor for regulation by HIV-1 Tat |
| Q31072762 | Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle |
| Q35893644 | Potentiation of human immunodeficiency virus type 1 Tat by human cellular proteins |
| Q40405826 | Prediction of common folding structures of homologous RNAs |
| Q40066451 | Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts |
| Q36828491 | Premature termination of tubulin gene transcription in Xenopus oocytes is due to promoter-dependent disruption of elongation |
| Q36654359 | Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity |
| Q39550188 | R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs. |
| Q27480815 | RNA-protein interactions: involvement of NS3, NS5, and 3' noncoding regions of Japanese encephalitis virus genomic RNA |
| Q40365664 | Regulation of eukaryotic gene expression by transcriptional attenuation |
| Q40756505 | Regulation of human immunodeficiency virus infection: implications for pathogenesis |
| Q30467457 | Retroviruses and cancer: models for cancer in animals and humans |
| Q34961590 | Rotational symmetry in ribonucleotide strand requirements for binding of HIV-1 Tat protein to TAR RNA |
| Q27480875 | Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA |
| Q36763035 | Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population |
| Q39872155 | Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat |
| Q24561778 | Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein |
| Q33937528 | Specific binding of a basic peptide from HIV-1 Rev |
| Q24645046 | Structural and functional analysis of the visna virus Rev-response element |
| Q36825248 | Structural requirements of 5S rRNA for nuclear transport, 7S ribonucleoprotein particle assembly, and 60S ribosomal subunit assembly in Xenopus oocytes |
| Q24644981 | Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1 |
| Q36642378 | TAR RNA binding properties and relative transactivation activities of human immunodeficiency virus type 1 and 2 Tat proteins. |
| Q40062345 | TAR-independent replication of human immunodeficiency virus type 1 in glial cells |
| Q24555668 | TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation |
| Q35993736 | Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine |
| Q24564637 | Tat-dependent occlusion of the HIV poly(A) site |
| Q36698552 | The Bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site |
| Q54336954 | The HIV-1 nucleocapsid protein does not function as a transcriptional activator on its own cognate promoter. |
| Q43822559 | The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists |
| Q38320497 | The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat |
| Q34978577 | The preprotachykinin A promoter interacts with a sequence specific single stranded DNA binding protein |
| Q39580918 | The secondary structure of the R region of a murine leukemia virus is important for stimulation of long terminal repeat-driven gene expression. |
| Q40467653 | Transactivation of Cellular Genes by Human Retroviruses |
| Q35855656 | Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression |
| Q24550872 | Transcriptional activation domains of human heat shock factor 1 recruit human SWI/SNF |
| Q41810274 | Transcriptional activation domains stimulate initiation and elongation at different times and via different residues |
| Q36637681 | Transcriptional activation of the herpes simplex virus type 1 UL38 promoter conferred by the cis-acting downstream activation sequence is mediated by a cellular transcription factor |
| Q40825617 | Transcriptional antitermination |
| Q36828988 | Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences |
| Q36699989 | Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas |
| Q39272683 | Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA. |
| Q39101871 | Unusual Fusion Proteins of HIV-1 |
| Q35114827 | Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques |
| Q35925617 | Variable inhibition of cell-free translation by HIV-1 transcript leader sequences |
| Q37220038 | What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? |
Search more.